CD4 and myeloid sarcoma: At baseline, 13 microRNAs in CD4+ T cells (miR-16, miR-17-5p, miR-17-92, miR-27, miR-29b, miR-126, miR-128, miR-155, miR-326, miR-550, and miR-340) and miR-132 in B cells were overexpressed, implying that they are likely dysregulated and involved in the pathogenesis of MS.